Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 548.12 | 575 / 578 | 84% | 10.87 | 965 / 1155 |
breast | 89% | 315.08 | 407 / 459 | 90% | 16.96 | 1002 / 1118 |
thymus | 84% | 438.68 | 550 / 653 | 66% | 11.08 | 398 / 605 |
prostate | 81% | 286.43 | 198 / 245 | 64% | 4.85 | 322 / 502 |
kidney | 65% | 302.54 | 58 / 89 | 71% | 7.01 | 643 / 901 |
stomach | 67% | 194.99 | 242 / 359 | 66% | 7.52 | 188 / 286 |
uterus | 66% | 237.00 | 113 / 170 | 61% | 4.92 | 279 / 459 |
intestine | 62% | 1721.35 | 602 / 966 | 63% | 6.56 | 332 / 527 |
skin | 39% | 87.71 | 698 / 1809 | 85% | 31.08 | 400 / 472 |
bladder | 67% | 285.90 | 14 / 21 | 57% | 5.51 | 285 / 504 |
esophagus | 52% | 158.25 | 750 / 1445 | 60% | 5.62 | 109 / 183 |
lymph node | 0% | 0 | 0 / 0 | 100% | 203.43 | 29 / 29 |
peripheral blood | 100% | 6765.73 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 11314.84 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.01 | 1 / 1 |
liver | 69% | 137.00 | 157 / 226 | 24% | 2.90 | 99 / 406 |
pancreas | 18% | 28.71 | 59 / 328 | 75% | 14.47 | 133 / 178 |
muscle | 92% | 633.99 | 741 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 15.74 | 41 / 45 |
adipose | 91% | 497.09 | 1091 / 1204 | 0% | 0 | 0 / 0 |
ovary | 33% | 68.90 | 59 / 180 | 53% | 3.04 | 229 / 430 |
eye | 0% | 0 | 0 / 0 | 63% | 4.97 | 50 / 80 |
heart | 53% | 137.14 | 455 / 861 | 0% | 0 | 0 / 0 |
brain | 1% | 2.35 | 38 / 2642 | 28% | 1.55 | 197 / 705 |
blood vessel | 29% | 99.45 | 384 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 10% | 14.12 | 26 / 258 | 14% | 0.82 | 32 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0038093 | Biological process | Fc receptor signaling pathway |
GO_0160006 | Biological process | Fc receptor-mediated immune complex endocytosis |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050855 | Biological process | regulation of B cell receptor signaling pathway |
GO_0002455 | Biological process | humoral immune response mediated by circulating immunoglobulin |
GO_0006968 | Biological process | cellular defense response |
GO_0002414 | Biological process | immunoglobulin transcytosis in epithelial cells |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0002172 | Molecular function | high-affinity IgM receptor activity |
GO_0001790 | Molecular function | polymeric immunoglobulin binding |
GO_0001791 | Molecular function | IgM binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FCMR |
Protein name | Fc mu receptor Immunoglobulin mu Fc receptor (IgM FcR) (Fas apoptotic inhibitory molecule 3) (FAIM3) (Regulator of Fas-induced apoptosis Toso) |
Synonyms | FAIM3 TOSO |
Description | FUNCTION: High-affinity Fc receptor for immunoglobulin M (IgM), both secreted and membrane-bound IgM . Primarily regulates IgM transport and homeostasis. Primarily regulates IgM transport and homeostasis. In lymphoid cells, enables exocytosis of membrane-bound IgM on the plasma membrane as well as endocytosis of IgM-antigen complexes toward lysosomes for degradation. In mucosal epithelium, mediates retrotranscytosis of antigen-IgM complexes across mucosal M cells toward antigen-presenting cells in mucosal lymphoid tissues . Triggers costimulatory signaling and mediates most of IgM effector functions involved in B cell development and primary immune response to infection. Likely limits tonic IgM BCR signaling to self-antigens for proper negative selection of autoreactive B cells in the bone marrow and for the maintenance of regulatory B cell pool in peripheral lymphoid organs. Mediates antibody responses to T cell-dependent and T cell-independent antigens and promotes induction of an efficient neutralizing IgG response. Engages in cross-talk with antigen-receptor signaling via the non-canonical NF-kappa-B, MAP kinases and calcium signaling pathways . . |
Accessions | E9PQG1 ENST00000442471.4 [O60667-2] ENST00000529560.1 ENST00000530505.1 ENST00000525793.5 E9PMT7 ENST00000367091.8 [O60667-1] O60667 ENST00000628511.2 [O60667-3] E9PPV1 ENST00000463473.2 E9PN59 |